Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma by FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ

Get full text

Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics by Busse WW, Pavord ID, Siddiqui S, Khan AH, Praestgaard A, Nash S, Jacob-Nara JA, Rowe PJ, Deniz Y

Get full text

Liberty asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-se... by Busse, WW, Maspero, JF, Rabe, KF, Papi, A, Wenzel, SE, Ford, LB, Pavord, ID, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Akinlade, B, Eckert, L, Chao, J, Graham, NMH, Teper, A

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization by Corren J, Jackson DJ, Casale TB, Borish L, Rabe KF, Busse WW, Maspero JF, Jackson DJ, Daizadeh N, Altincatal A, Radwan A, Khodzhayev A, Djandji M, Jacob-Nara JA, Rowe PJ, Deniz Y

Get full text

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis by Maspero, JF, Katelaris, CH, Busse, WW, Castro, M, Corren, J, Chipps, BE, Peters, AT, Pavord, ID, Ford, LB, Sher, L, Rabe, KF, Rice, MS, Rowe, P, Lu, Y, Harel, S, Jagerschmidt, A, Khan, A, Kamat, S, Pirozzi, G, Amin, N, Ruddy, M, Graham, NMH, Mannent, L, Teper, A

A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma by Castro, M, Corren, J, Pavord, ID, Maspero, JF, Wenzel, SE, Rabe, KF, Busse, WW, Ford, LB, Sher, L, Fitzgerald, JM, Katelaris, C, Tohda, Y, Zhang, B, Staudinger, H, Pirozzi, G, Amin, N, Ruddy, M, Akinlade, B, Khan, A, Chao, J, Martincova, R, Graham, NMH, Teper, A